Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/11/26 08:47 | 2/10/26 | ENTX | Health | BioPrd | Biological Products, (No Diag | Taitel Haya | L3 | D | 1 | P | 11 | 1.48 | 0 | 8 | 0 | D | ||||||||||||||||
2/11/26 08:45 | 2/10/26 | ENTX | Health | BioPrd | Biological Products, (No Diag | Germano Geno J | L3 | D | 1 | P | 30 | 1.49 | 0 | 20 | 0 | D | ||||||||||||||||
2/11/26 08:44 | 2/9/26 | ENTX | Health | BioPrd | Biological Products, (No Diag | Rubin Steven D | L3 | D | 1 | P | 12 | 1.20 | 0 | 10 | 10 | D | ||||||||||||||||
2/11/26 08:42 | 2/9/26 | ENTX | Health | BioPrd | Biological Products, (No Diag | Ellis Sean | L3 | D | 1 | P | 22 | 1.24 | 0 | 18 | 11 | 178 | D | |||||||||||||||
12/30/25 06:01 | 12/29/25 | ENTX | Health | BioPrd | Biological Products, (No Diag | Toledano Miranda Jayne | L3 | DO | CEO | 1 | P | 20 | 1.81 | 0 | 11 | 3 | 427 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |